Unlock stock picks and a broker-level newsfeed that powers Wall Street.
567.09
-24.77
(-4.19%)
At close: April 1 at 4:00:01 PM EDT
Research Analysis
Earnings Estimate
| Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 8 | 7 |
| Avg. Estimate | 1.92 | 2.46 | 12.4 | 20.44 |
| Low Estimate | 1.57 | 2.25 | 9.73 | 14.13 |
| High Estimate | 2.06 | 2.68 | 18.12 | 25.56 |
| Year Ago EPS | -0.97 | 0.41 | 1.58 | 12.4 |
Revenue Estimate
| Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 15 | 15 | 26 | 25 |
| Avg. Estimate | 748.62M | 815.29M | 3.38B | 4.34B |
| Low Estimate | 704.59M | 745.86M | 2.94B | 3.62B |
| High Estimate | 816.47M | 887.16M | 3.83B | 5.37B |
| Year Ago Sales | 383.84M | 450.91M | 2.14B | 3.38B |
| Sales Growth (year/est) | 95.03% | 80.81% | 57.60% | 28.47% |
Earnings History
| Currency in EUR | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.81 | -0.99 | 0.06 | 1.7 |
| EPS Actual | -0.97 | 0.41 | 1.28 | 0.71 |
| Difference | -0.16 | 1.41 | 1.22 | -0.99 |
| Surprise % | -19.93% | 141.80% | 2,138.78% | -58.04% |
EPS Trend
| Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 1.92 | 2.46 | 12.4 | 20.44 |
| 7 Days Ago | 1.97 | 2.51 | 12.06 | 20.26 |
| 30 Days Ago | 1.98 | 2.43 | 9.89 | 19.03 |
| 60 Days Ago | 1.87 | 2.34 | 9.46 | 18.63 |
| 90 Days Ago | 1.71 | 2.09 | 8.48 | 17.95 |
EPS Revisions
| Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 2 | 2 |
| Up Last 30 Days | 2 | 2 | 5 | 4 |
| Down Last 7 Days | 2 | 2 | 2 | 2 |
| Down Last 30 Days | 2 | 2 | 3 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ARGX | 298.90% | 492.57% | 683.65% | 64.81% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Maintains | Guggenheim: Buy to Buy | 3/10/2025 |
| Maintains | Baird: Neutral to Neutral | 3/4/2025 |
| Maintains | Oppenheimer: Outperform to Outperform | 2/28/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 2/28/2025 |
| Maintains | Citizens Capital Markets: Outperform to Outperform | 2/28/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 2/28/2025 |
Related Tickers
ALNY Alnylam Pharmaceuticals, Inc.
255.76
-5.28%
BPMC Blueprint Medicines Corporation
85.94
-2.90%
ASND Ascendis Pharma A/S
151.43
-2.84%
KRYS Krystal Biotech, Inc.
174.58
-3.17%
IMVT Immunovant, Inc.
15.20
-11.06%
RVMD Revolution Medicines, Inc.
33.62
-4.92%
INSM Insmed Incorporated
72.00
-5.62%
GMAB Genmab A/S
18.66
-4.70%
CRNX Crinetics Pharmaceuticals, Inc.
30.62
-8.71%
BHVN Biohaven Ltd.
22.60
-5.99%